SOUTH SAN FRANCISCO, Calif.-(BUSINESS WIRE)-Exelixis, Inc. (Nasdaq:EXEL) announced that today it granted restricted stock units representing an aggregate of 25,200 shares of Exelixis common stock to nine new employees. The restricted stock unit awards vest as to 1/4th of the (…)
[Read article]
[Source: Business Wire]
FT LAUDERDALE, Fla.-(BUSINESS WIRE)-As the State of Florida grapples with a budget shortfall that is crippling its AIDS Drug Assistance Program (ADAP) and forcing the state to place more than 1,300 low-income Floridians on waiting lists to access lifesaving AIDS medications, (…)
[Read article]
[Source: Business Wire]
RALEIGH, NC-(Marketwire - September 01, 2010) - Highlighted Links macreport InoLife Technologies, Inc. (OTCBB: INOL), a service based healthcare products development, integration and marketing Company, announced today it will provide and market a proprietary metabolizing test (…)
[Read article]
[Source: BioSpace]
ScienceDaily (Aug. 31, 2010) The data monitoring committee of the AVERROES study, seeing overwhelming evidence of the success of apixaban in the prevention of stroke in patients with atrial fibrillation who are unsuitable for the conventional treatment of warfarin, has (…)
[Read article]
[Source: ScienceDaily]
On August 29 at the European Cardiovascular Society Congress meeting in Stockholm, Sweden, Dr. Guillaume Paré presented new research conducted by McMaster University that in fact contradicts earlier reports that Plavix (clopidogrel) does not work in people with a certain (…)
[Read article]
[Source: Medical News Today]
The data monitoring committee of the AVERROES study, seeing overwhelming evidence of the success of apixaban in the prevention of stroke in patients with atrial fibrillation who are unsuitable for the conventional treatment of warfarin, has recommended early termination of this (…)
[Read article]
[Source: Medical News Today]
DUBLIN-(BUSINESS WIRE)-Research and Markets (http:/www.researchandmarkets.com/research/66a1b1/philippines_pharma) has announced the addition of the "Philippines Pharmaceuticals and Healthcare Report Q4 2010" report to their offering. Philippines Pharmaceuticals and (…)
[Read article]
[Source: Business Wire]
STOCKHOLM, Aug 31 (Reuters) - An experimental drug from Bristol-Myers Squibb (BMY.N) and Pfizer (PFE.N) reduces the risk of stroke by more than half compared with aspirin, with no significant rise in major bleeding, researchers said on Tuesday.
[Read article]
[Source: BioSpace]
ScienceDaily (Aug. 29, 2010) New findings by McMaster University researchers contradict earlier reports that people with a certain genetic make-up don't benefit from the blood-thinner clopidogrel, also known as Plavix. See Also: Health & Medicine Stroke Prevention Heart Disease (…)
[Read article]
[Source: ScienceDaily]
LOS ANGELES-(BUSINESS WIRE)-AIDS Healthcare Foundation (AHF), the largest global AIDS organization, today announced that its online community has grown to 100,000 people, including 64,643 Facebook followers and 32,690 members of its website e-community. The group credits its (…)
[Read article]
[Source: Business Wire]
DUBLIN-(BUSINESS WIRE)-Research and Markets (http:/www.researchandmarkets.com/research/37adf0/eli_lilly_co_p) has announced the addition of the "Eli Lilly & Co.: PharmaVitae Profile" company profile to their offering. Introduction This analysis examines the historical and (…)
[Read article]
[Source: Business Wire]
DUBLIN-(BUSINESS WIRE)-Research and Markets (http:/www.researchandmarkets.com/research/aabcf1/johnson_johnson) has announced the addition of the "Johnson & Johnson: PharmaVitae Profile" company profile to their offering. Introduction This analysis examines the historical and (…)
[Read article]
[Source: Business Wire]
STOCKHOLM, SWEDEN-(Marketwire - August 30, 2010) - Portola Pharmaceuticals, Inc. today announced results from the Phase 2 INNOVATE-PCI study of its investigational antiplatelet drug, elinogrel, the only competitive, reversible direct-acting P2Y12 ADP receptor antagonist. (…)
[Read article]
[Source: BioSpace]
Sermo, the world's largest online community for physicians, announced a free Sermo Report titled, "FDA Committee Recommends Approval for Ticagrelor." The report covers physician opinions about the introduction of an investigational oral antiplatelet treatment for acute coronary (…)
[Read article]
[Source: Medical News Today]
DUBLIN-(BUSINESS WIRE)-Research and Markets (http:/www.researchandmarkets.com/research/883f56/novel_antibodies_a) has announced the addition of the "Novel Antibodies and Therapeutic Proteins - Technology Challenges and Future Prospects" report to their offering. Novel (…)
[Read article]
[Source: Business Wire]
Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that the increased generic erosion of key drugs such as lamotrigine (GlaxoSmithKline's Lamictal, generics) and divalproex (Abbott/Sanofi-Aventis's (…)
[Read article]
[Source: Medical News Today]
DUBLIN-(BUSINESS WIRE)-Research and Markets (http:/www.researchandmarkets.com/research/614240/fixed_dose_combina) has announced the addition of the "Fixed Dose Combination Products" report to their offering. Fixed dose combination (FDC) products are becoming increasingly (…)
[Read article]
[Source: Business Wire]
DUBLIN-(BUSINESS WIRE)-Research and Markets (http:/www.researchandmarkets.com/research/768ea0/forecast_insight) has announced the addition of the "Forecast Insight: Hepatitis B - Baraclude and Viread set to thrive in the face of limited competition" report to their offering. (…)
[Read article]
[Source: Business Wire]
DUBLIN-(BUSINESS WIRE)-Maven Semantic (http:/www.mavensemantic.com) announces updates to their Antibacterial research database. The system uses the context in which a given person appears, using artificial intelligence techniques to find out information not otherwise visible (…)
[Read article]
[Source: Business Wire]
DUBLIN-(BUSINESS WIRE)-Research and Markets (http:/www.researchandmarkets.com/research/360241/best_practices_in) has announced the addition of the "Best Practices in Working with Patient Advocacy Groups: Building Effective Relationships" report to their offering. Best (…)
[Read article]
[Source: Business Wire]
DUBLIN-(BUSINESS WIRE)-Research and Markets (http:/www.researchandmarkets.com/research/e9e8b4/educating_the_mark) has announced the addition of the "Educating the Market: Creating Value Through Support of Continuing Medical Education 2010" report to their offering. Educating (…)
[Read article]
[Source: Business Wire]
SEATTLE-(BUSINESS WIRE)-ZymoGenetics, Inc. (NASDAQ:ZGEN) today announced enrollment has been completed in the Phase 2b clinical trial with PEG-Interferon lambda and ribavirin in chronic hepatitis C virus (HCV) infection. ZymoGenetics is investigating PEG-Interferon lambda in (…)
[Read article]
[Source: Business Wire]
DUBLIN-(BUSINESS WIRE)-Maven Semantic (http:/www.mavensemantic.com) announces updates to their Biomarker research database. The system uses the context in which a given person appears, using artificial intelligence techniques to find out information not otherwise visible - (…)
[Read article]
[Source: Business Wire]
RESEARCH TRIANGLE PARK, N.C.-(BUSINESS WIRE)-Tranzyme Pharma announced today that John Wo, MD, Professor of Medicine, Director, Clinical Research, Division of Gastroenterology, Hepatology and Nutrition, University of Louisville, Louisville, KY, will present ulimorelin Phase 2 (…)
[Read article]
[Source: Business Wire]
PRINCETON, N.J. & NEW YORK-(BUSINESS WIRE)-Bristol-Myers Squibb Company (NYSE: BMY) and Pfizer (NYSE: PFE) report that preliminary results from the Phase 3 AVERROES clinical trial of the investigational drug apixaban compared with acetylsalicylic acid (ASA, or aspirin) in (…)
[Read article]
[Source: Business Wire]
Metabolism of two broad spectrum quinolones in advanced preclinical development-tosufloxacin and BMY 43748-was compared in hepatocyte cultures derived from rat, dog, monkey and humans. The drugs were added at the first medium renewal and incubated for 4 or 24 hr in serum-free (…)
[Read article]
[Source: NCBI PubMed]
The design, synthesis, and structure-activity relationships (SAR) of a series of 2-aminothiazol-5-yl-pyrimidines as novel p38alpha MAP kinase inhibitors are described. These efforts led to the identification of 41 as a potent p38alpha inhibitor that utilizes a unique (…)
[Read article]
[Source: NCBI PubMed]
With the aim of developing a kidney cell culture system that can be used to assess renal toxicity in vivo, freshly isolated rabbit proximal tubules were plated on Millipore cellulose filters mounted in plastic inserts (Millicell-HA). DNA synthesis peaked on day 6 of culture and (…)
[Read article]
[Source: NCBI PubMed]
SEATTLE-(BUSINESS WIRE)-ZymoGenetics, Inc. (NASDAQ:ZGEN) today announced enrollment has been completed in the Phase 2b clinical trial with PEG-Interferon lambda and ribavirin in chronic hepatitis C virus (HCV) infection. ZymoGenetics is investigating PEG-Interferon lambda in (…)
[Read article]
[Source: BioSpace]
PRINCETON, N.J. & NEW YORK-(BUSINESS WIRE)-Bristol-Myers Squibb Company (NYSE: BMY) and Pfizer (NYSE: PFE) report that preliminary results from the Phase 3 AVERROES clinical trial of the investigational drug apixaban compared with acetylsalicylic acid (ASA, or aspirin) in (…)
[Read article]
[Source: BioSpace]
CAMBRIDGE, Mass.-(BUSINESS WIRE)-Ensemble Therapeutics announced today the presentation of data on its macrocyclic-based drug discovery platform at the American Chemical Society (ACS) National Meeting August 22-26, in Boston at the Boston Convention and Exposition Center. The (…)
[Read article]
[Source: Business Wire]
Importance of the field: Kidney transplantation is the best treatment for end-stage kidney-disease patients. However, despite major breakthroughs in the last decades, and the progresses made with immunosuppressants, the long-term results still need to be improved. This is (…)
[Read article]
[Source: NCBI PubMed]
DUBLIN-(BUSINESS WIRE)-Research and Markets (http:/www.researchandmarkets.com/research/e3c0d9/market_access_in_j) has announced the addition of Decision Resources, Inc.'s new report "Market Access in Japan: New Challenges and Opportunities for the Pharmaceutical Industry" to (…)
[Read article]
[Source: Business Wire]
DUBLIN-(BUSINESS WIRE)-Research and Markets (http:/www.researchandmarkets.com/research/bd425b/biomarkers_discov) has announced the addition of the "Biomarkers: Discovery Techniques and Applications A Global Market Overview" report to their offering. Biomarkers: Discovery (…)
[Read article]
[Source: Business Wire]
PRINCETON, N.J.-(BUSINESS WIRE)-Bristol-Myers Squibb Company (NYSE: BMY) today announced that the U.S. Food and Drug Administration (FDA) has accepted, for filing and review, the Biologics License Application (BLA) for ipilimumab for the treatment of adult patients with (…)
[Read article]
[Source: Business Wire]
WATERTOWN, Mass.-(BUSINESS WIRE)-Wolfe Laboratories, Inc. (WLI) will host the 2010 Wolfe Biopharma Conference, Emerging Markets and Technologies: 2020 VisionTM, on Tuesday, October 19, 2010 at The Ritz-Carlton, Boston Common. Pharmaceutical sales in emerging markets are (…)
[Read article]
[Source: Business Wire]
PRINCETON, N.J.-(BUSINESS WIRE)-Bristol-Myers Squibb Company (NYSE: BMY - News) today announced that the U.S. Food and Drug Administration (FDA) has accepted, for filing and review, the Biologics License Application (BLA) for ipilimumab for the treatment of adult patients (…)
[Read article]
[Source: BioSpace]
DUBLIN-(BUSINESS WIRE)-Maven Semantic (http:/www.mavensemantic.com) announces updates to their Bioavailability / Bioequivalence database. The system uses the context in which a given person appears, using artificial intelligence techniques to find out information not (…)
[Read article]
[Source: Business Wire]
DUBLIN-(BUSINESS WIRE)-Research and Markets (http:/www.researchandmarkets.com/research/7f25f4/the_cardiovascular) has announced the addition of the "The Cardiovascular Market Outlook to 2015: Competitive Landscape, Global Market Analysis, Key Trends and Pipeline analysis" (…)
[Read article]
[Source: Business Wire]
DUBLIN-(BUSINESS WIRE)-Research and Markets (http:/www.researchandmarkets.com/research/89d247/bristolmyers_squi) has announced the addition of the "Bristol-Myers Squibb Co.: PharmaVitae Profile" company profile to their offering. This analysis examines the historical and (…)
[Read article]
[Source: Business Wire]
ROCKVILLE, MD-(Marketwire - August 16, 2010) - MarketResearch.com has announced the addition of GBI Research's new report "The Future of High Potency Active Pharmaceutical Ingredients (HPAPIs), Market Forecasts and Growth Opportunities to 2015 - Growing Demand Drives (…)
[Read article]
[Source: Marketwire]
DUBLIN-(BUSINESS WIRE)-Research and Markets (http:/www.researchandmarkets.com/research/2061ac/effective_social_m) has announced the addition of the "Effective Social Media Marketing Strategies for Pharmaceutical Market" report to their offering. Effective Social Media (…)
[Read article]
[Source: Business Wire]